| Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More | Frank Vinluan | 03/13/20 | National |
| Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More | Sarah de Crescenzo | 03/06/20 | National |
| Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More | Ben Fidler | 07/05/19 | National |
| Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More | Frank Vinluan | 06/21/19 | National |
| Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More | Frank Vinluan | 03/30/18 | National |
| Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies | Frank Vinluan | 03/29/18 | Boston |
| Bio Roundup: Trump Health, Cholesterol Wars, 23andMe OK & More | Alex Lash | 03/09/18 | National |
| Unum, Homology Plan IPOs, as Unum Reveals Two Patient Deaths | Frank Vinluan | 03/05/18 | Boston |
| AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down | Alex Lash | 04/06/17 | National |
| Ever Fond of Options, Atlas Finds Potential Buyers For Rodin, Quartet | Ben Fidler | 01/06/16 | Boston |
| LabCentral Backers Planning $150M Venture Fund For Biotech Startups | Alex Lash | 10/21/15 | Boston |
| Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy | Ben Fidler | 09/18/15 | National |
| RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B | Ben Fidler | 07/23/15 | Boston |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus | Alex Lash | 06/11/15 | Seattle |
| IPO “On the Horizon” for Unum After $65M Series B, CEO Says | Ben Fidler | 06/11/15 | Boston |
| Unum Therapeutics Receives $65,000,000 Series B Financing | VentureDeal | 06/11/15 | Boston |
| Seattle Genetics Pays $25M to Buy Into Unum’s Souped-Up T-Cell Therapy | Ben Fidler | 06/08/15 | Boston |
| Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups | Ben Fidler | 04/17/15 | Boston |
| Seven Takeaways From “What’s Hot in Boston Biotech” | Ben Fidler | 04/10/15 | Boston |
| Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling | Angela Shah | 02/26/15 | Texas |
| Find Out “What’s Hot in Boston Biotech” on April 8 | Ben Fidler | 02/05/15 | Boston |
| Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO | Angela Shah | 12/18/14 | Texas |
| East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More | Ben Fidler | 12/05/14 | Boston |
| With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy | Ben Fidler | 12/01/14 | Boston |
| Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work | Ben Fidler | 11/17/14 | Seattle |
| East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More | Ben Fidler | 10/24/14 | Boston |
| Unum Therapeutics Lands $12,000,000 Series A Funding | VentureDeal | 10/22/14 | Boston |
| Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum | Ben Fidler | 10/21/14 | Boston |
